Viewing Study NCT06059261


Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2025-12-28 @ 11:49 AM
Study NCT ID: NCT06059261
Status: RECRUITING
Last Update Posted: 2024-08-06
First Post: 2023-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Sponsor: Chongqing University Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module